Eli Lilly and Co
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Scott Olson | Getty Images The Food and Drug Administration on Tuesday approved Eli Lilly‘s Alzheimer’s drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The […]
Read More
Shares generating the major midday moves: Tesla, Polestar, Paramount Global and much more
Test out the providers earning headlines in midday investing: Tesla — Tesla surged approximately 9% after the electrical automobile company claimed stronger-than-anticipated second-quarter deliveries. The Elon Musk-led organization sent 443,956 cars, though analysts polled by StreetAccount envisioned deliveries of 439,000. The determine confirmed a 4.8% decline from a year ago but was 14.8% previously mentioned […]
Read More
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Eli Lilly, Novo Nordisk and other drugmakers showed off encouraging data […]
Read More
Novo Nordisk’s Wegovy weight loss drug approved in China
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world’s second largest economy. China’s National Medical Products Administration “recently” […]
Read More
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies. Demand for […]
Read More
Shares generating the biggest moves midday: ResMed, Affirm, Nvidia, Anheuser-Busch and additional
Examine out the organizations generating the greatest moves midday: Encourage Clinical Devices , ResMed — Encourage Medical Units and ResMed, which manufacture units to take care of obstructive slumber apnea, dropped 14% and 11%, respectively, following Friday’s news that Eli Lilly ‘s body weight decline drug tirzepatide diminished the severity of the affliction. Eli Lilly […]
Read More
Shares producing the most important moves before the bell: Nvidia, Ferrari, World Fitness, Cinemark and more
Look at out the businesses producing headlines in premarket buying and selling. ResMed , Eli Lilly — ResMed tumbled 11.8% pursuing past week’s information that Eli Lilly’s tirzepatide weight reduction drug diminished the severity of obstructive snooze apnea. Eli Lilly, on the other hand, ticked bigger by all-around 1%. RXO — The freight stock surged […]
Read More
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year. If cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called obstructive […]
Read More
Excess weight loss drug contender Zealand Pharma jumps 23% on demo success
Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024. Bloomberg | Bloomberg | Getty Photos LONDON — Shares of Denmark’s Zealand Pharma popped approximately 23% in Friday early morning deals, notching a record higher soon after an early-phase analyze of its fat decline drug […]
Read More
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable weight loss medication Wegovy at New City Halstead Pharmacy in Chicago on April 24, 2024. Scott Olson | Getty Images Good morning! More U.S. employers are covering a buzzy class of medications called GLP-1s for weight […]
Read More